Mabion SA submitted in Bosnia full set of R&D and legal documents in order to register clinical trials of MabionCD20 medicine, which is used in therapy of blood cancers and rheumatoid arthritis (RA). The application was delivered to 6 bioethical commissions in Bosnia and in the Council of Registratio...
Read more